scholarly article | Q13442814 |
P50 | author | Denis Servent | Q46913748 |
P2093 | author name string | André Ménez | |
Bernard Gilquin | |||
Elodie Marcon | |||
Gilles Mourier | |||
Sophie Zinn-Justin | |||
Catherine Marquer | |||
Carole Fruchart-Gaillard | |||
Guillaume Letellier | |||
P2860 | cites work | The structural basis for agonist and partial agonist action on a β(1)-adrenergic receptor | Q24594844 |
Structure of a nanobody-stabilized active state of the β(2) adrenoceptor | Q24597139 | ||
GPCRDB: information system for G protein-coupled receptors | Q24616648 | ||
Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists | Q24619974 | ||
Structure and function of an irreversible agonist-β(2) adrenoceptor complex | Q24620291 | ||
The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist | Q24654563 | ||
High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor | Q24657484 | ||
Structural response to mutation at a protein-protein interface | Q27617450 | ||
Motions and structural variability within toxins: Implication for their use as scaffolds for protein engineering | Q27640337 | ||
Crystal structure of the human beta2 adrenergic G-protein-coupled receptor | Q27648868 | ||
Structure of a beta1-adrenergic G-protein-coupled receptor | Q27651011 | ||
Different interactions between MT7 toxin and the human muscarinic M1 receptor in its free and N-methylscopolamine-occupied states | Q27652082 | ||
Structure of the Human Dopamine D3 Receptor in Complex with a D2/D3 Selective Antagonist | Q27666030 | ||
Comparative protein modelling by satisfaction of spatial restraints | Q27860866 | ||
Identification of G protein-coupled receptor genes from the human genome sequence | Q28202262 | ||
GPCR engineering yields high-resolution structural insights into beta2-adrenergic receptor function | Q28254935 | ||
Discovering high-affinity ligands for proteins: SAR by NMR | Q29617569 | ||
Seven-transmembrane receptors | Q29619896 | ||
Formation and dissociation of M1 muscarinic receptor dimers seen by total internal reflection fluorescence imaging of single molecules | Q30493203 | ||
Data-driven docking for the study of biomolecular complexes | Q30980755 | ||
Data-driven docking: HADDOCK's adventures in CAPRI. | Q30992986 | ||
Docking of antizyme to ornithine decarboxylase and antizyme inhibitor using experimental mutant and double-mutant cycle data | Q33451459 | ||
Recent progress in fragment-based lead discovery | Q33455221 | ||
Evolution of protein binding modes in homooligomers | Q33618229 | ||
Rescue of defective G protein-coupled receptor function in vivo by intermolecular cooperation. | Q33719668 | ||
Estimation of the affinities of allosteric ligands using radioligand binding and pharmacological null methods. | Q46016726 | ||
Atypical muscarinic allosteric modulation: cooperativity between modulators and their atypical binding topology in muscarinic M2 and M2/M5 chimeric receptors | Q46699162 | ||
Identification of various allosteric interaction sites on M1 muscarinic receptor using 125I-Met35-oxidized muscarinic toxin 7. | Q46913704 | ||
Allosteric small molecules unveil a role of an extracellular E2/transmembrane helix 7 junction for G protein-coupled receptor activation | Q46985701 | ||
A dissection of specific and non-specific protein-protein interfaces | Q47737233 | ||
Identification and molecular characterization of m3 muscarinic receptor dimers | Q48177207 | ||
Crystallographic refinement by knowledge-based exploration of complex energy landscapes. | Q48549817 | ||
Energetics of protein-protein interactions: analysis of the barnase-barstar interface by single mutations and double mutant cycles. | Q49187978 | ||
Identification of a novel pharmacophore for peptide toxins interacting with K+ channels. | Q50664253 | ||
A structure refinement method based on molecular dynamics in four spatial dimensions. | Q52386873 | ||
Spatial localization of the K+ channel selectivity filter by mutant cycle-based structure analysis. | Q52546897 | ||
CHARMM: A program for macromolecular energy, minimization, and dynamics calculations | Q53340989 | ||
Complementarity of Structure Ensembles in Protein-Protein Binding | Q57815055 | ||
Critical Role for the Second Extracellular Loop in the Binding of Both Orthosteric and Allosteric G Protein-coupled Receptor Ligands | Q57838214 | ||
Stable allosteric binding of m1-toxin to m1 muscarinic receptors | Q72665997 | ||
Dissecting protein-protein recognition sites | Q77926233 | ||
On the dynamic nature of the transition state for protein-protein association as determined by double-mutant cycle analysis and simulation | Q80461475 | ||
Allosteric interactions with muscarinic acetylcholine receptors: complex role of the conserved tryptophan M2422Trp in a critical cluster of amino acids for baseline affinity, subtype selectivity, and cooperativity | Q83206375 | ||
Energetic and structural interactions between delta-dendrotoxin and a voltage-gated potassium channel | Q33891879 | ||
Structure of the interferon-receptor complex determined by distance constraints from double-mutant cycles and flexible docking | Q33949253 | ||
Flexible protein-protein docking | Q33993623 | ||
Experimentally based model of a complex between a snake toxin and the alpha 7 nicotinic receptor | Q34017212 | ||
Structure of the BgK-Kv1.1 complex based on distance restraints identified by double mutant cycles. Molecular basis for convergent evolution of Kv1 channel blockers | Q34140443 | ||
Including receptor flexibility and induced fit effects into the design of MMP-2 inhibitors | Q34175711 | ||
Monomeric G-protein-coupled receptor as a functional unit | Q34431199 | ||
Target validation of G-protein coupled receptors | Q34525952 | ||
Assembly reflects evolution of protein complexes | Q34787237 | ||
Heavier-than-air flying machines are impossible. | Q35757370 | ||
A monomeric G protein-coupled receptor isolated in a high-density lipoprotein particle efficiently activates its G protein | Q35778121 | ||
Time-resolved FRET between GPCR ligands reveals oligomers in native tissues. | Q36422842 | ||
Toxin insights into nicotinic acetylcholine receptors | Q36485022 | ||
Emergence of symmetry in homooligomeric biological assemblies. | Q36945073 | ||
Dimerization and oligomerization of G-protein-coupled receptors: debated structures with established and emerging functions | Q37098373 | ||
Muscarinic toxins: tools for the study of the pharmacological and functional properties of muscarinic receptors | Q37490228 | ||
Orthosteric/allosteric bitopic ligands: going hybrid at GPCRs. | Q37547722 | ||
Bioinformatics and molecular modelling approaches to GPCR oligomerization. | Q37656672 | ||
Structural biology in fragment-based drug design | Q37752790 | ||
Homomeric protein complexes: evolution and assembly | Q37775639 | ||
A model of a gp120 V3 peptide in complex with an HIV-neutralizing antibody based on NMR and mutant cycle-derived constraints | Q38315995 | ||
Pirenzepine promotes the dimerization of muscarinic M1 receptors through a three-step binding process | Q39849760 | ||
A novel mechanism of G protein-coupled receptor functional selectivity. Muscarinic partial agonist McN-A-343 as a bitopic orthosteric/allosteric ligand. | Q39947679 | ||
Quantitative analysis of muscarinic acetylcholine receptor homo- and heterodimerization in live cells: regulation of receptor down-regulation by heterodimerization | Q40337775 | ||
A variable residue in the pore of Kv1 channels is critical for the high affinity of blockers from sea anemones and scorpions | Q40423398 | ||
Muscarinic toxin 7 selectivity is dictated by extracellular receptor loops. | Q40479466 | ||
Monomers and oligomers of the M2 muscarinic cholinergic receptor purified from Sf9 cells | Q40620568 | ||
Detection, quantitation, and verification of allosteric interactions of agents with labeled and unlabeled ligands at G protein-coupled receptors: interactions of strychnine and acetylcholine at muscarinic receptors. | Q42277559 | ||
Building macromolecular assemblies by information-driven docking: introducing the HADDOCK multibody docking server | Q42427876 | ||
Lack of evidence for AT1R/B2R heterodimerization in COS-7, HEK293, and NIH3T3 cells: how common is the AT1R/B2R heterodimer? | Q42806160 | ||
Crystal structure of a Cbtx-AChBP complex reveals essential interactions between snake alpha-neurotoxins and nicotinic receptors. | Q42844842 | ||
Influence of MT7 toxin on the oligomerization state of the M1 muscarinic receptor. | Q43156439 | ||
Inhibition of acetylcholine muscarinic M(1) receptor function by the M(1)-selective ligand muscarinic toxin 7 (MT-7). | Q43264495 | ||
Chemical synthesis of MT1 and MT7 muscarinic toxins: critical role of Arg-34 in their interaction with M1 muscarinic receptor. | Q44253596 | ||
Allosteric site on muscarinic acetylcholine receptors: identification of two amino acids in the muscarinic M2 receptor that account entirely for the M2/M5 subtype selectivities of some structurally diverse allosteric ligands in N-methylscopolamine-o | Q44483391 | ||
Interactions of orthosteric and allosteric ligands with [3H]dimethyl-W84 at the common allosteric site of muscarinic M2 receptors | Q44483424 | ||
Biophysics: is rhodopsin dimeric in native retinal rods? | Q44645841 | ||
The retinal conformation and its environment in rhodopsin in light of a new 2.2 A crystal structure | Q45029374 | ||
Conserved structural determinants in three-fingered protein domains | Q45106348 | ||
Design of tRNA(Lys)3 ligands: fragment evolution and linker selection guided by NMR spectroscopy | Q45328799 | ||
P433 | issue | 36 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cell biology | Q7141 |
G protein-coupled receptor | Q38173 | ||
P304 | page(s) | 31661-75 | |
P577 | publication date | 2011-09-09 | |
P1433 | published in | Journal of Biological Chemistry | Q867727 |
P1476 | title | Structural model of ligand-G protein-coupled receptor (GPCR) complex based on experimental double mutant cycle data: MT7 snake toxin bound to dimeric hM1 muscarinic receptor | |
P478 | volume | 286 |
Q27675253 | Conopeptide -TIA Defines a New Allosteric Site on the Extracellular Surface of the 1B-Adrenoceptor |
Q27678423 | Crystallization of recombinant green mamba ρ-Da1a toxin during a lyophilization procedure and its structure determination |
Q35860873 | Distinct Agonist Regulation of Muscarinic Acetylcholine M2-M3 Heteromers and Their Corresponding Homomers |
Q21134520 | Engineering of three-finger fold toxins creates ligands with original pharmacological profiles for muscarinic and adrenergic receptors |
Q43479740 | High-throughput production of two disulphide-bridge toxins. |
Q47788379 | Interpreting the structural mechanism of action for MT7 and human muscarinic acetylcholine receptor 1 complex by modeling protein-protein interaction |
Q39765332 | Molecular conversion of muscarinic acetylcholine receptor M(5) to muscarinic toxin 7 (MT7)-binding protein. |
Q37608542 | Molecular determinants of allosteric modulation at the M1 muscarinic acetylcholine receptor. |
Q47348671 | Opportunities and Challenges in the Discovery of Allosteric Modulators of GPCRs |
Q34918713 | Orthosteric binding of ρ-Da1a, a natural peptide of snake venom interacting selectively with the α1A-adrenoceptor |
Q29871448 | Secreted Isoform of Human Lynx1 (SLURP-2): Spatial Structure and Pharmacology of Interactions with Different Types of Acetylcholine Receptors |
Q40660620 | Structural Insight into Specificity of Interactions between Nonconventional Three-finger Weak Toxin from Naja kaouthia (WTX) and Muscarinic Acetylcholine Receptors |
Q97535797 | Structure and selectivity engineering of the M1 muscarinic receptor toxin complex |
Q47234473 | The Predictive Power of Different Types of Experimental Restraints in Small Molecule Docking: A Review |
Q28547175 | The Repellent DEET Potentiates Carbamate Effects via Insect Muscarinic Receptor Interactions: An Alternative Strategy to Control Insect Vector-Borne Diseases |
Q36935273 | The prevalence, maintenance, and relevance of G protein-coupled receptor oligomerization |
Q38741858 | The three-finger toxin fold: a multifunctional structural scaffold able to modulate cholinergic functions. |
Search more.